股票代码：******
网站地图
Oct 06,2014
Hypertension vaccine expected to be available within five years
In the near future, some hypertension patients may be able to effectively control their blood pressure simply by receiving a vaccine injection. This therapeutic vaccine is the result of years of research by a Swiss pharmaceutical company. Currently, the vaccine is still in small-scale clinical trials, with 48 hypertension patients having completed one injection course. The expected blood pressure-lowering effect can last for about 4 months. It is reported that the vaccine will be marketed within five years, and the related research results have been published in the renowned British medical journal The Lancet. The hypertension vaccine mainly targets the renin-angiotensin system; once injected into the body, the vaccine "infects" the patient and stimulates the immune system
Oct 06,2014
Zhejiang established the nation's first non-profit joint drug procurement center
On August 18, more than 50 pharmacy owners from 11 cities in Zhejiang Province gathered in Hangzhou to officially establish the "Zhejiang Province Pharmaceutical Retail (Chain) Enterprise Joint Procurement Center." They decided to collectively conduct drug bidding with pharmaceutical manufacturers to reduce costs and seek new development opportunities. This is the first non-profit joint drug procurement center in Zhejiang Province and even nationwide. Industry insiders say this marks a shift in the pharmacy industry from passive price reductions to "active initiatives." The development of pharmacies has reached a freezing point. One of the initiators of this joint procurement center, Lin Zhenhua, General Manager of Hangzhou Buyi Pharmacy, told reporters that since 2002
Add:
Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China
Board Office:
Complaint & Report Hotline:
Pharmacovigilance Hotline:
Company Email:
Investor Relations:
International Sales Email:
Complaint/Report Email:
WeChat mini-site
WeChat official account
© Copyright 2025 Jiangxi Institute of Biological Products Inc. | SEO
Business License
Powered by www.300.cn